IDH1 and astrocytoma (excluding glioblastoma): However, significant publication bias was found to influence the reporting of neurologic complications in studies that evaluated LITT for IDH-mutant astrocytoma (β = −6.2, p < 0.01) (Supplementary Figure S2).